Razan Mohty

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Razan Mohty, Assistant Professor at UAB Medicine, shared a paper she and her colleagues authored on X:

“Happy to share our recent manuscript on outcomes of anti-CD19 CART for lymphoma in octogenarians (80 years of age or older).

– CR rate 71.4%
– 1-year OS 61.2%
– 1-year PFS 47.6%
– 1-year NRM 11.6%

Thanks to all collaborators.”

Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study

Authors: Mohamed A. Kharfan-Dabaja, Razan Mohty et al.

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Aaron P. Rapoport Amer Beitinjaneh Amitkumar Mehta Arushi Khurana Bhagirathbhai Dholaria cancer Deepa Jagadeesh Ernesto Ayala Forat Lutfi Frederick L. Locke Javier Munoz Jean Yared Jennifer Logue Jose Sandoval-Sus Joseph McGuirk Joshua Fein Julio C. Chavez Kaitlin Annunzio Lazaros Lekakis Madiha Iqbal Mayur Narkhede Mehdi Hamadani Michael D. Jain Mohamed A. Kharfan-Dabaja Muhamad Alhaj-Moustafa Narendranath Epperla Nausheen Ahmed Neela Easwar Olalekan O. Oluwole OncoDaily Oncology Othman Salim Akhtar Patrick Johnston Praveen Ramakrishnan Geethakumari Razan Mohty Samuel Yamshon Tsiporah Shore Urshila Durani Usama Gergis Yi Lin